Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Otto

Showing results (511-520 of 541) with videos related to

Pageof 55
Sort By:
JAMA Network Open|June 5, 2020
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical TrialJasper A J Smits, Mark H Pollack, David Rosenfield, et al.
Depression and Anxiety|July 30, 2020
Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trialJenna R Carl, Christopher B Miller, Alasdair L Henry, et al.
The American Journal of Psychiatry|February 2, 2006
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Roy H Perlis, Michael J Ostacher, Jayendra K Patel, et al.
Annals of the Rheumatic Diseases|December 23, 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositisMeredyth G Ll Wilkinson, Dale Moulding, Thomas C R McDonnell, et al.
The American Journal of Pathology|August 21, 2010
Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromesCarlos J Perez, Jean Jaubert, Jean-Louis Guénet, et al.
Archives of General Psychiatry|April 4, 2007
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement ProgramDavid J Miklowitz, Michael W Otto, Ellen Frank, et al.
The American Journal of Psychiatry|August 31, 2007
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trialDavid J Miklowitz, Michael W Otto, Ellen Frank, et al.
Scientific Reports|March 8, 2019
Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease TreatmentFrancois Brial, Aurélie Le Lay, Lyamine Hedjazi, et al.
Biological Psychiatry|June 6, 2003
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)Gary S Sachs, Michael E Thase, Michael W Otto, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 4, 2006
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disordersM W Otto, N M Simon, S R Wisniewski, et al.
Pageof 55

Showing results (511-520 of 541) with videos related to

Sort By:
Pageof 55
JAMA Network Open|June 5, 2020
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical TrialJasper A J Smits, Mark H Pollack, David Rosenfield, et al.
Depression and Anxiety|July 30, 2020
Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trialJenna R Carl, Christopher B Miller, Alasdair L Henry, et al.
The American Journal of Psychiatry|February 2, 2006
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Roy H Perlis, Michael J Ostacher, Jayendra K Patel, et al.
Annals of the Rheumatic Diseases|December 23, 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositisMeredyth G Ll Wilkinson, Dale Moulding, Thomas C R McDonnell, et al.
The American Journal of Pathology|August 21, 2010
Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromesCarlos J Perez, Jean Jaubert, Jean-Louis Guénet, et al.
Archives of General Psychiatry|April 4, 2007
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement ProgramDavid J Miklowitz, Michael W Otto, Ellen Frank, et al.
The American Journal of Psychiatry|August 31, 2007
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trialDavid J Miklowitz, Michael W Otto, Ellen Frank, et al.
Scientific Reports|March 8, 2019
Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease TreatmentFrancois Brial, Aurélie Le Lay, Lyamine Hedjazi, et al.
Biological Psychiatry|June 6, 2003
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)Gary S Sachs, Michael E Thase, Michael W Otto, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 4, 2006
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disordersM W Otto, N M Simon, S R Wisniewski, et al.
Pageof 55